BNR
Burning Rock Biotech Limited
NASDAQ · Healthcare · Medical - Diagnostics & Research · CN
$11.03
+2.32%Margins
Gross margin
74.6%
EBITDA margin
-4.5%
EBIT margin
-11.4%
Net margin
-11.5%
FCF margin
-7.7%
-11.5%
Return on equity
-7.5%
Return on assets
-10.3%
Return on invested capital
0.64x
Asset turnover
-$5.1M
Cash from operations
$6.30
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026